David B. Johnson
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Hematology top 5%
Papers in
- Co-authors
- Lei Wang (3 shared papers)Matthew D. Schultz (2 shared papers)Jianfeng Xu (2 shared papers)Robert J. Schmitz (2 shared papers)Joseph R. Ecker (2 shared papers)Jeff A. Sloan (5 shared papers)Charles L. Loprinzi (5 shared papers)Zhouxin Shen (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Lung Cancer (3 papers)Supportive Care in Cancer (2 papers)Cancer (2 papers)Pediatric Emergency Care (1 paper)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
David B. Johnson
56 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 120
- Oncology 471
- Hematology 140
- Pulmonary and Respiratory Medicine 353
- Molecular Biology 643
- Dermatology 73
Countries citing papers authored by David B. Johnson
This map shows the geographic impact of David B. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Johnson more than expected).
Fields of papers citing papers by David B. Johnson
This network shows the impact of papers produced by David B. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Johnson. The network helps show where David B. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 282 | |
| 2 | 2003 | 165 | |
| 3 | 2010 | 132 | |
| 4 | 2008 | 130 | |
| 5 | 1982 | 97 | |
| 6 | 1997 | 96 | |
| 7 | 2012 | 93 | |
| 8 | 2003 | 89 | |
| 9 | 2005 | 88 | |
| 10 | 2010 | 70 | |
| 11 | 2009 | 67 | |
| 12 | 1999 | 62 | |
| 13 | 1995 | 59 | |
| 14 | 2003 | 57 | |
| 15 | 1989 | 53 | |
| 16 | Native Hawaiians mortality, morbidity, and lifestyle: comparing data from 1982, 1990, and 2000. | 2004 | 48 |
| 17 | 2000 | 47 | |
| 18 | 1987 | 46 | |
| 19 | 1996 | 45 | |
| 20 | 2001 | 40 |
About David B. Johnson
David B. Johnson is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 57 papers that have together received 2.1k indexed citations. Recurring topics across this work include Orthopedic Surgery and Rehabilitation (5 papers), Cancer Treatment and Pharmacology (4 papers), Total Knee Arthroplasty Outcomes (4 papers), Lung Cancer Treatments and Mutations (4 papers), Muscle and Compartmental Disorders (3 papers), Bone fractures and treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (471 citations), Hematology (140 citations), Pulmonary and Respiratory Medicine (353 citations), Molecular Biology (643 citations) and Dermatology (73 citations). David B. Johnson has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Lei Wang, Matthew D. Schultz, Jianfeng Xu, Robert J. Schmitz, Joseph R. Ecker, Jeff A. Sloan, Charles L. Loprinzi, Zhouxin Shen, Steven P. Briggs and Jeffrey K. Takimoto. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Supportive Care in Cancer, Cancer and Pediatric Emergency Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.